Tatsuya Usui

625 total citations
19 papers, 506 citations indexed

About

Tatsuya Usui is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tatsuya Usui has authored 19 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tatsuya Usui's work include Histone Deacetylase Inhibitors Research (4 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Tatsuya Usui is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Tatsuya Usui collaborates with scholars based in Japan, United States and Taiwan. Tatsuya Usui's co-authors include Hideyuki Yamawaki, Muneyoshi Okada, Tomoka Morita, Yukio Hara, Takashi Ohama, Koichi Sato, Shunya Tsuji, Mayuko Oda, Satoshi Kameshima and Masashi Sakurai and has published in prestigious journals such as PLoS ONE, Scientific Reports and Hypertension.

In The Last Decade

Tatsuya Usui

18 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tatsuya Usui Japan 12 334 111 80 50 47 19 506
Jian Yin China 15 385 1.2× 71 0.6× 94 1.2× 33 0.7× 36 0.8× 29 610
Jun Zheng China 15 310 0.9× 109 1.0× 174 2.2× 43 0.9× 43 0.9× 45 593
Wan-Ru Lee United States 12 276 0.8× 69 0.6× 59 0.7× 31 0.6× 33 0.7× 12 515
Anne‐Sophie Ay France 9 311 0.9× 58 0.5× 80 1.0× 47 0.9× 27 0.6× 11 435
Eileen Vesely United States 7 328 1.0× 48 0.4× 83 1.0× 55 1.1× 28 0.6× 8 486
Hui‐Jun Mu China 13 220 0.7× 83 0.7× 61 0.8× 27 0.5× 73 1.6× 32 434
Rangasudhagar Radhakrishnan United States 13 424 1.3× 123 1.1× 158 2.0× 23 0.5× 48 1.0× 28 599
Chiara Baldacci Italy 11 206 0.6× 162 1.5× 58 0.7× 40 0.8× 27 0.6× 14 771
Mi-Ni Lee South Korea 11 264 0.8× 114 1.0× 92 1.1× 21 0.4× 30 0.6× 11 435

Countries citing papers authored by Tatsuya Usui

Since Specialization
Citations

This map shows the geographic impact of Tatsuya Usui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuya Usui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuya Usui more than expected).

Fields of papers citing papers by Tatsuya Usui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuya Usui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuya Usui. The network helps show where Tatsuya Usui may publish in the future.

Co-authorship network of co-authors of Tatsuya Usui

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuya Usui. A scholar is included among the top collaborators of Tatsuya Usui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuya Usui. Tatsuya Usui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Salahudeen, Ameen A., José A. Seoane, Kanako Yuki, et al.. (2023). Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis. Cell Reports. 42(11). 113355–113355. 8 indexed citations
2.
Tsuji, Shunya, Kazuhiro Yoshimura, Masashi Sakurai, et al.. (2018). Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis. Molecular Cancer Research. 16(3). 554–563. 39 indexed citations
3.
Tsuji, Shunya, Satoru Mochida, Tsuyoshi Ikehara, et al.. (2018). A stable association with PME‐1 may be dispensable for PP2A demethylation – implications for the detection of PP2A methylation and immunoprecipitation. FEBS Open Bio. 8(9). 1486–1496. 21 indexed citations
4.
Usui, Tatsuya, et al.. (2017). Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling. Oncology Reports. 37(2). 1100–1106. 24 indexed citations
6.
Ueda, Shin-ya, et al.. (2017). Effects of walking in water on gut hormone concentrations and appetite: comparison with walking on land. Endocrine Connections. 7(1). 97–106. 4 indexed citations
7.
Tsuji, Shunya, Takayuki Nakagawa, Hao‐Ping Liu, et al.. (2017). The role of SET/I2PP2A in canine mammary tumors. Scientific Reports. 7(1). 4279–4279. 10 indexed citations
8.
Usui, Tatsuya, et al.. (2017). Establishment of a novel three-dimensional primary culture model for hippocampal neurogenesis. Physiological Reports. 5(12). e13318–e13318. 4 indexed citations
9.
Usui, Tatsuya, Masashi Sakurai, Takashi Ohama, et al.. (2016). Establishment of a Novel Model for Anticancer Drug Resistance in Three‐Dimensional Primary Culture of Tumor Microenvironment. Stem Cells International. 2016(1). 7053872–7053872. 42 indexed citations
10.
Tsuji, Shunya, et al.. (2016). Anti-tumor effects of perphenazine on canine lymphoma. Journal of Veterinary Medical Science. 78(8). 1293–1298. 9 indexed citations
11.
Usui, Tatsuya, et al.. (2015). Protein Phosphatase Methyl-Esterase PME-1 Protects Protein Phosphatase 2A from Ubiquitin/Proteasome Degradation. PLoS ONE. 10(12). e0145226–e0145226. 31 indexed citations
12.
Fujiwara, Nobuyuki, Shunya Tsuji, Michael P. Vitek, et al.. (2015). The therapeutic effects of SET/I2PP2A inhibitors on canine melanoma. Journal of Veterinary Medical Science. 77(11). 1451–1456. 18 indexed citations
13.
Usui, Tatsuya, Kyosuke Kazama, Tomoka Morita, et al.. (2014). Death-associated protein kinase 3 mediates vascular structural remodelling via stimulating smooth muscle cell proliferation and migration. Clinical Science. 127(8). 539–548. 19 indexed citations
14.
Usui, Tatsuya, et al.. (2014). Eukaryotic elongation factor 2 kinase controls proliferation and migration of vascular smooth muscle cells. Acta Physiologica. 213(2). 472–480. 27 indexed citations
15.
Usui, Tatsuya, Muneyoshi Okada, & Hideyuki Yamawaki. (2013). Zipper interacting protein kinase (ZIPK): function and signaling. APOPTOSIS. 19(2). 387–391. 32 indexed citations
16.
Usui, Tatsuya, Tomoka Morita, Muneyoshi Okada, & Hideyuki Yamawaki. (2013). Histone Deacetylase 4 Controls Neointimal Hyperplasia via Stimulating Proliferation and Migration of Vascular Smooth Muscle Cells. Hypertension. 63(2). 397–403. 68 indexed citations
17.
Usui, Tatsuya, Muneyoshi Okada, Yukio Hara, & Hideyuki Yamawaki. (2012). Death-Associated Protein Kinase 3 Mediates Vascular Inflammation and Development of Hypertension in Spontaneously Hypertensive Rats. Hypertension. 60(4). 1031–1039. 59 indexed citations
18.
Usui, Tatsuya, Muneyoshi Okada, Mayuko Oda, et al.. (2012). HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology. 302(9). H1894–H1904. 82 indexed citations
19.
Okada, Seiji, et al.. (1980). Hereditary adenosine deaminase deficiency detected by screening test.. PubMed. 31(1-2). 13–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026